Research and teaching

Research and teaching

Contact us
to discuss gift opportunities

  • Emeritus Professor Chris Lowe OBE with David Holden-White (Churchill 2014), Master's in Bioscience Enterprise student
    Emeritus Professor Chris Lowe OBE with David Holden-White (Churchill 2014), Master's in Bioscience Enterprise student

Our senior academics set the agenda. It is through their expertise and leadership that we discover extraordinary things and train the next generation.

The competition to attract the world’s most brilliant minds is fierce and we must ensure that we have the resources we need to endow academic posts, which can be filled by the world's best thinkers, so Cambridge can continue to compete at a global level.

We want to make sure that we have the skills and expertise to lead the world in new fields of inquiry, continuing the Cambridge tradition of setting the global benchmark for standards of education, learning and research. Crucial to this is the endowment of fellowships, lectureships and professorships, so that Cambridge continues to attract and provide for the world's best thinkers. Endowing these academic posts is at the heart of the plan for the University's future as it is the senior academics who lead our extraordinary research projects and shape the next generation of researchers and thinkers.

Related stories

Illustration of a nerve cell
The recently-launched Milner Therapeutics Institute and Consortium aims to tackle some of today’s most globally devastating diseases, including cancer and Alzheimer’s.
Wolfson Laser Lab
In 2016 the Department of Chemical Engineering and Biotechnology will bid farewell to central Cambridge and move into its new £60m purpose-built home on the West Cambridge Science and Technology Campus.
The new Laboratory of Molecular Biology at Addenbrooke's hospital
At any one time, more than 1000 clinical trials are being conducted across the Cambridge Biomedical Campus, the largest gathering of clinical, pharmaceutical and biomedical research specialists in Europe. These trials are a crucial step in the design of new medicines and medical devices – translating ideas that started in a research laboratory into new treatments for patients.
Faculty of Law
As new research and technologies transform medicine, so too they change the nature of health issues, medico-legal dilemmas and the realities of health care systems, from consent and confidentiality to public health and biosecurity.
Mother holding hands with a newborn baby
Every year, 550,000 women worldwide die due to complications in pregnancy or childbirth and 20 million babies are born with low birth weight.
A piece of Persian art
The 11th-century epic poem the Shahnama holds a hugely important place in Persian culture. Richly illustrated manuscripts of the work, by Firdausi of Tus, can be found in libraries around the world, recounting the history of the ancient kings of Iran from mythical beginnings to the Arab conquest in 651 AD.
Indian farmer holding a small seedling
One of the biggest challenges of the 21st century is developing prevention strategies, treatments and vaccinations to combat infectious diseases, which kill more people worldwide than any other medical condition.
Chris Lowe, Emeritus Professor (right) is pictured with David Holden-White
“Life sciences are the founding stone of entrepreneurship, the key to growing the economy and society” explains Darrin Disley, Chief Executive and Co-founder of Horizon Discovery Group, a translational genomics company credited with bringing about an era of personalised medicine.
Dr Brigitte 'Ita' Askonas, 1923-2013
Dr Brigitte ‘Ita’ Askonas was revered as one of the world’s leading immunologists, and equally renowned for her warm, collaborative support of fellow researchers. So it is a fitting tribute to such an iconic scientist that Cambridge is able to continue Ita’s passion for developing early career researchers through the Ita Askonas Bursaries, funded by her generous legacy to the University.
'Hubble peers at the heart of a spiral galaxy' shows NGC 5793, over 150 million light-years away in the constellation of Libra
It could be the first line of a joke: there was a philosopher, a software engineer and a scientist. But the birth of the Cambridge Centre for the Study of Existential Risk (CSER) is no laughing matter.
Dr Andrew Conlan, Alborada Post-doctoral Fellow in Epidemiology
A pioneering scheme that engages schoolchildren with maths is also helping scientists work towards understanding the spread of diseases such as measles, thanks to Dr Andrew Conlan.
Dr Annettee Nakimuli
Dr Annettee Nakimuli, a lecturer in the Department of Obstetrics and Gynaecology of Makerere University, Uganda, (MUII) became involved with the Cambridge-Africa Programme at the start of her PhD studies.
Dr Stefano Pluchino
Dr Stefano Pluchino holds the John van Geest Lectureship in Brain Repair and through the support of the John and Lucille van Geest Foundation is able to research new ways of using stem cells to combat brain damage.
Microscopic photograph of the hippocampus demonstrating the characteristics of Alzheimer’s disease
The development of new treatments for diseases such as Alzheimer’s and Parkinson’s is one step closer thanks to the generous support of the Frances and Augustus Newman Foundation.